Tryp Therapeutics Inc.
TRYPF · OTC
8/31/2023 | 8/31/2022 | 8/31/2021 | 8/31/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$5,267 | -$7,495 | -$8,255 | -$423 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $363 | $275 | $2,462 | $0 |
| Change in WC | $986 | $1,108 | -$365 | $175 |
| Other Non-Cash | $296 | $304 | $1,096 | $211 |
| Operating Cash Flow | -$3,622 | -$5,809 | -$5,063 | -$36 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$8 | -$138 | -$25 | -$4 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | -$0 | -$0 | -$0 | -$0 |
| Investing Cash Flow | -$8 | -$138 | -$25 | -$4 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $4,150 | $7,003 | $1,069 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $2,146 | $4,137 | $7,761 | $1,060 |
| Financing Cash Flow | $2,146 | $4,137 | $7,761 | $1,060 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$1,484 | -$1,810 | $2,673 | $1,019 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1,882 | $3,692 | $1,019 | $0 |
| End Cash | $398 | $1,882 | $3,692 | $1,019 |
| Free Cash Flow | -$3,630 | -$5,947 | -$5,087 | -$41 |